MUDENG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.610400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.522400E-01
Normal-vs-Stage2
5.948000E-01
Normal-vs-Stage3
1.693930E-02
Normal-vs-Stage4
7.634800E-01
Stage1-vs-Stage2
4.009600E-01
Stage1-vs-Stage3
4.486200E-02
Stage1-vs-Stage4
7.660200E-01
Stage2-vs-Stage3
4.181700E-02
Stage2-vs-Stage4
2.442400E-01
Stage3-vs-Stage4
7.827900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.277600E-01
Normal-vs-AfricanAmerican
8.633800E-01
Normal-vs-Asian
7.278400E-01
Caucasian-vs-AfricanAmerican
3.072000E-01
Caucasian-vs-Asian
9.710000E-01
AfricanAmerican-vs-Asian
5.319600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.049600E-01
Normal-vs-Female
8.157400E-01
Male-vs-Female
2.785200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.314600E-01
Normal-vs-Age(41-60Yrs)
9.449600E-01
Normal-vs-Age(61-80Yrs)
4.686200E-01
Normal-vs-Age(81-100Yrs)
3.324800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.839200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.310600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.955200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.632140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.169430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.535800E-01
Normal-vs-Daily Drinker
2.214800E-01
Normal-vs-Weekly Drinker
2.945200E-01
Normal-vs-Occasional Drinker
8.265200E-01
Normal-vs-Social Drinker
8.713200E-01
Non Drinker-vs-Daily Drinker
6.619600E-01
Non Drinker-vs-Weekly Drinker
7.365400E-01
Non Drinker-vs-Occasional Drinker
1.534570E-01
Non Drinker-vs-Social Drinker
1.673210E-01
Daily Drinker-vs-Weekly Drinker
9.794200E-01
Daily Drinker-vs-Occasional Drinker
7.068100E-02
Daily Drinker-vs-Social Drinker
1.135980E-01
Weekly Drinker-vs-Occasional Drinker
1.345580E-01
Weekly Drinker-vs-Social Drinker
1.375180E-01
Occasional Drinker-vs-Social Drinker
5.643800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.904800E-01
Normal-vs-Grade 2
5.710000E-02
Normal-vs-Grade 3
9.078400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.424400E-01
Grade 1-vs-Grade 3
3.575400E-01
Grade 1-vs-Grade 4
1.904800E-01
Grade 2-vs-Grade 3
3.888200E-01
Grade 2-vs-Grade 4
5.710000E-02
Grade 3-vs-Grade 4
9.078400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.728800E-01
Normal-vs-NonDiabetic
6.468800E-01
Diabetic-vs-NonDiabetic
1.830000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.875900E-02
Normal-vs-NoPancreatitis
6.260600E-01
Pancreatitis-vs-NoPancreatitis
1.104610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.650400E-01
Normal-vs-N1
6.016000E-01
N0-vs-N1
8.486800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.138200E-01
Normal-vs-TP53-NonMutant
9.205000E-01
TP53-Mutant-vs-TP53-NonMutant
4.863600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
